<DOC>
	<DOCNO>NCT02747303</DOCNO>
	<brief_summary>The objective compare 2 mm v 0 mm PTV margin respect local PFS risk radionecrosis treat intact brain metastasis LINAC-based frameless SRS</brief_summary>
	<brief_title>The Clinical Relevance Margins Frameless Stereotactic Radiosurgery Intact Brain Metastases : Randomized Trial 0 v 2 mm Margins</brief_title>
	<detailed_description>PRIMARY OBJECTIVE The primary objective evaluate non-inferiority frameless LINAC-based SRS use 0 mm GTV PTV margin ( experimental arm ) compare 2 mm GTV PTV margin ( standard arm ) local PFS 6 month treatment intact brain metastasis . SECONDARY OBJECTIVES To evaluate superiority frameless LINAC-based SRS use 0 mm margin compare 2 mm margin reduce rate radiation necrosis pseudoprogression . EXPLORATIVE OBJECTIVES - To compare rate local PFS 1 year 2 year - To compare rate local failure 6 month , 1 year 2 year - To compare rate OS 6 month , 1 year 2 year - To compare rate acute ( within 90 day SRS ) Common Terminology Criteria Adverse Events ( CTCAE ) v5.0 central nervous system ( CNS ) Grade 2+ Grade 3+ toxicity . - To compare rate late ( great 90 day SRS ) CTCAE v5.0 CNS Grade 2+ Grade 3+ toxicity . - To compare rate distant intracranial failure . - To compare rate salvage therapy intracranial failure . - To determine association V10Gy V12Gy tissue , whole brain normal brain parameter risk radionecrosis pseudoprogression .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>. Adult patient ( ≥ 18 year old ) ECOG Performance Status 02 life expectancy 3 month . ii . Histologically confirm systemic malignancy gadolinium contrastenhanced MRI scan demonstrate 15 intraparenchymal brain metastasis . iii . Wellcircumscribed , measureable intraparenchymal brain lesion ( ) maximum tumor diameter ≤3.0 cm . If multiple lesion present , ( ) must exceed 3.0 cm maximum diameter . At least one lesion must ≥1.0 cm maximum diameter ≥0.5 cm perpendicular diameter consider measurable disease . iv . Negative urine serum pregnancy test do ≤ 14 day prior SRS , woman childbearing potential . v. Ability understand willingness sign write informed consent document . . Diagnosis germ cell tumor , small cell carcinoma hematologic malignancy . ii . Metastases brain stem , midbrain , pons , medulla , within 7 mm optic apparatus ( optic nerve , chiasm optic tract ) . iii . Diagnosis leptomeningeal disease . iv . Prior history radiation therapy involve brain . v. Chemotherapy ( include oral agent targeted agent ) immunotherapy give within 14 day SRS . Hormonal therapy permit . For Her2+ breast cancer patient , antiHer2 therapy give within 14 day SRS . Patients schedule receive trastuzumab emtansine SRS enrol . vi . Contraindications gadolinium contrastenhanced MRI ( eg , noncompatible pacemaker , eGFR &lt; 30 , gadolinium allergy ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>brain metastasis</keyword>
	<keyword>Stereotactic Radiosurgery</keyword>
</DOC>